Timbang, Evangeline B.
HRN: 23-64-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
CEFUROXIME 500MG (TAB)
08/31/2023
08/31/2023
PO
500mg
Q12
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTIMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes